chevron_leftBack
As of 9 June 2026, Icure Pharmaceutical InCorp. has a market cap of $53.1M USD, ranking #30311 globally and #1702 in South Korea.
It ranks #2741 in the Healthcare sector, and #157 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$53.1MUSD
81.09B KRW
Enterprise Value
$75.54MUSD
115.36B KRW
Revenue (TTM)
$54.6MUSD
83.38B KRW
EBITDA (TTM)
-$7.57MUSD
-11.55B KRW
Net Income (TTM)
-$22.0MUSD
-33.6B KRW
EBITDA Margin
-14%
Profit Margin
-40%
PS Ratio
1.0
PB Ratio
2.9
Company Profile
Country (HQ)
Sector
Healthcare
CEO
Young-Kwon Choi
open_in_new
Employees
220
Founded
2000
Website
icure.co.kr
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 12% | 20% | 13% | 5.9% | 28% | -25% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
175250
아이큐어(주)
ISIN: KR7175250000
Shares Out.:
Shares Outstanding:
37.37M1
Shares Float:
31.526M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
2,170 KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Icure Pharmaceutical InCorp.
Icure Pharmaceutical Incorporation, a biopharmaceutical company, researches, develops, and sells pharmaceutical and cosmetic products in South Korea. The company offers functional, nature-derived, derma, and customized cosmetics products. It also offers eye gel, hydro nude gel, lip gel mask, and functional patch products; and sheet, mud, foil, and melting masks. In addition, the company provides body and haircare products, including naturally derived hair and baby line, cleansing tissue, and wet wipes. Further, it offers perfumes, textile perfumes, body mists, and hair and body fragrances. Icure Pharmaceutical Incorporation was founded in 2000 and is based in Seoul, South Korea.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
KRX: 317450
|
$541.14M
919%
826.36B KRW
|
8.4
|
|
KRX: 220100
|
$279.13M
426%
426.25B KRW
|
-
|
|
KRX: 200130
|
$219.38M
313%
335.01B KRW
|
-
|
|
KRX: 009290
|
$204.06M
284%
311.61B KRW
|
16.3
|
|
KRX: 194700
|
$167.85M
216%
256.31B KRW
|
7.4
|
|
KRX: 011040
|
$99.15M
87%
151.41B KRW
|
17.8
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TLV: TEVA
|
$37.17B
70K%
108.92B ILS
|
24.2
|
|
NASDAQ: RVMD
|
$29.56B
56K%
|
-
|
|
SHE: 002001
|
$15.86B
30K%
107.34B CNY
|
16.0
|
|
NSE: CIPLA
|
$11.16B
21K%
1.06T INR
|
23.4
|
|
NSE: LUPIN
|
$11.04B
21K%
1.05T INR
|
22.7
|
|
SHE: 002653
|
$9.1B
17K%
61.6B CNY
|
80.6
|
chevron_leftBack